Viewing Study NCT07092202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-04-25 @ 5:24 AM
Study NCT ID: NCT07092202
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2025-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leptomeningeal Metastasis View
None NSCLC View
None Intrathecal Chemotherapy View
None Tyrosine Kinase Inhibitor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leptomeningeal metastasis View
None NSCLC View
None Intrathecal Chemotherapy View
None Firmonertinib View
None Tyrosine Kinase Inhibitor View
None cfDNA View